Michael A Metzger - Net Worth and Insider Trading
Michael A Metzger Net Worth
The estimated net worth of Michael A Metzger is at least $347,706 dollars as of 2024-11-06. Michael A Metzger is the CEO of Syndax Pharmaceuticals Inc and owns about 17,659 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $347,706. Michael A Metzger is also the Director of CTI BioPharma Corp and owns about 0 shares of CTI BioPharma Corp (CTIC) stock worth over $0. Details can be seen in Michael A Metzger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael A Metzger has not made any transactions after 2023-02-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael A Metzger
Michael A Metzger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A Metzger owns 4 companies in total, including CTI BioPharma Corp (CTIC) , Syndax Pharmaceuticals Inc (SNDX) , and Regado Biosciences Inc (RGDO) among others .
Click here to see the complete history of Michael A Metzger’s form 4 insider trades.
Insider Ownership Summary of Michael A Metzger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2022-11-08 | director |
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-06 | President and COO |
| RGDO | Regado Biosciences Inc | 2014-12-03 | director & President & CEO |
 | | 2012-07-30 | director |
Michael A Metzger Latest Holdings Summary
Michael A Metzger currently owns a total of 2 stocks. Among these stocks, Michael A Metzger owns 17,659 shares of Syndax Pharmaceuticals Inc (SNDX) as of February 6, 2023, with a value of $347,706 and a weighting of 100%. Michael A Metzger also owns 0 shares of CTI BioPharma Corp (CTIC) as of November 8, 2022, with a value of $0 and a weighting of 0%.
Latest Holdings of Michael A Metzger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2023-02-06 | 17,659 | 19.69 | 347,706 |
| CTIC | CTI BioPharma Corp | 2022-11-08 | 0 | 9.09 | 0 |
Holding Weightings of Michael A Metzger
Michael A Metzger Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A Metzger has made a total of 14 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 5,959 shares on February 6, 2023, which brought Michael A Metzger around $164,707.
According to the SEC Form 4 filings, Michael A Metzger has made a total of 3 transactions in CTI BioPharma Corp (CTIC) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in CTI BioPharma Corp is the sale of 91,500 shares on November 8, 2022, which brought Michael A Metzger around $510,570.
Insider Trading History of Michael A Metzger
- 1
Michael A Metzger Trading Performance
Michael A Metzger Ownership Network
Ownership Network List of Michael A Metzger
Ownership Network Relation of Michael A Metzger
Michael A Metzger Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Michael A Metzger is the director of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Michael A Metzger Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A Metzger. You might contact Michael A Metzger via mailing address: C/o Syndax Pharmaceuticals, Inc., 400 Totten Pond Road,, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
